XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Capital Stock [Member]
Other Equity [Member]
Statutory Surplus Reserve [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive (Loss) Income [Member]
Non-controlling Interests [Member]
Balance, beginning of period at Dec. 31, 2021   $ 409,979 $ 174,620 $ 3,932 $ (234,975) $ 2,527  
Balance, beginning of period at Dec. 31, 2021             $ 73,531
Movement of Shareholders' Equity              
Amortization of share-based payment expense - stock options     370        
Amortization of share-based payment expense - restricted share units     10,212        
Amortization of share-based payment expense - performance stock units     3,717        
Common shares repurchased and retired   (28,768)     (20,587)    
Restricted share units vested   9,896 (13,708)        
Net income (loss) attributable to common shareholders $ (16,460)       (16,460)    
Net income (loss) attributable to non-controlling interests 259           275
Other comprehensive loss, net of tax (13,021)         (9,282)  
Other comprehensive loss, net of tax             (3,739)
Dividends paid to non-controlling shareholders of IMAX China             (2,610)
Share-based compensation attributable to non-controlling interests             399
Change in ownership interest related to IMAX China common share repurchases     (543)       (1,301)
Balance, end of period at Jun. 30, 2022   391,107 174,668 3,932 (272,022) (6,755)  
Balance, end of period at Jun. 30, 2022             66,555
Balance, beginning of period at Mar. 31, 2022   415,362 167,912 3,932 (251,194) 3,228  
Balance, beginning of period at Mar. 31, 2022             74,081
Movement of Shareholders' Equity              
Amortization of share-based payment expense - stock options     139        
Amortization of share-based payment expense - restricted share units     5,862        
Amortization of share-based payment expense - performance stock units     1,863        
Common shares repurchased and retired   (25,106)     (17,977)    
Restricted share units vested   851 (1,108)        
Net income (loss) attributable to common shareholders (2,851)       (2,851)    
Net income (loss) attributable to non-controlling interests (1,400)           (1,381)
Other comprehensive loss, net of tax (13,889)         (9,983)  
Other comprehensive loss, net of tax             (3,906)
Dividends paid to non-controlling shareholders of IMAX China             (2,610)
Share-based compensation attributable to non-controlling interests             371
Balance, end of period at Jun. 30, 2022   391,107 174,668 3,932 (272,022) (6,755)  
Balance, end of period at Jun. 30, 2022             66,555
Movement of Shareholders' Equity              
Total shareholders' equity 357,485            
Total shareholders' equity 329,046            
Balance, beginning of period at Dec. 31, 2022 263,355 376,715 185,678 3,932 (293,124) (9,846)  
Balance, beginning of period at Dec. 31, 2022 65,691           65,691
Movement of Shareholders' Equity              
Amortization of share-based payment expense - stock options     92        
Amortization of share-based payment expense - restricted share units     7,324        
Amortization of share-based payment expense - performance stock units     3,125        
Common shares repurchased and retired   (97)     (1,889)    
Restricted share units vested   13,620 (20,845)        
Net income (loss) attributable to common shareholders 10,805       10,805    
Net income (loss) attributable to non-controlling interests 3,931           3,921
Other comprehensive loss, net of tax (6,931)         (4,776)  
Other comprehensive loss, net of tax             (2,155)
Dividends paid to non-controlling shareholders of IMAX China             (1,438)
Share-based compensation attributable to non-controlling interests             148
Balance, end of period at Jun. 30, 2023 270,714 390,238 175,374 3,932 (284,208) (14,622)  
Balance, end of period at Jun. 30, 2023 66,167           66,167
Balance, beginning of period at Mar. 31, 2023   389,500 170,871 3,932 (292,409) (7,876)  
Balance, beginning of period at Mar. 31, 2023             69,090
Movement of Shareholders' Equity              
Amortization of share-based payment expense - stock options     1        
Amortization of share-based payment expense - restricted share units     4,010        
Amortization of share-based payment expense - performance stock units     2,104        
Common shares repurchased and retired   (206)     (150)    
Restricted share units vested   944 (1,612)        
Net income (loss) attributable to common shareholders 8,351       8,351    
Net income (loss) attributable to non-controlling interests 1,262           1,261
Other comprehensive loss, net of tax (9,590)         (6,746)  
Other comprehensive loss, net of tax             (2,844)
Dividends paid to non-controlling shareholders of IMAX China             (1,438)
Share-based compensation attributable to non-controlling interests             98
Balance, end of period at Jun. 30, 2023 270,714 $ 390,238 $ 175,374 $ 3,932 $ (284,208) $ (14,622)  
Balance, end of period at Jun. 30, 2023 66,167           $ 66,167
Movement of Shareholders' Equity              
Total shareholders' equity $ 336,881